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Abstract 
This study was to investigate the antimicrobial resistance of coagulase-negative Staphylococci isolated in 8 
consecutive years in the First Bethune Hospital. Disk diffusion test was used to study the antimicrobial resistance. 
The data were analyzed by WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). 
Most of 2484 strains of coagulase-negative Staphylococci were collected from blood 925 (37.2%), secretions 652 
(26.2%) and urine 323 (13.0%) during the past 8 years. The rates of methicillin-resistant coagulase-negative 
Staphylococci (MRCNS) were between 79.4  and 81.5  during the past 8 years, respectively. In recent 8 years, 
the antimicrobial resistance of coagulase-negative Staphylococci had increased. Monitoring the antimicrobial 
resistance to coagulase-negatives Staphylococci should be strengthened. The change of the antimicrobial resistance 
should be investigated in order to direct rational drug usage in the clinic and prevent bacterial strain of drug resistance 
from being transmitted. 
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1.Introduction 
Coagulase-negative staphylococci are common pathogens of the blood stream, being frequently 
related to nosocomial infections, especially in neonates and immunocompromised patients; transmission 
usually involves medical devices, such as catheters and prostheses [1-3]. Methicillin-resistant 
coagulase-negative Staphylococci (MRCNS) are considered important agents of nosocomial infections 
and have frequently been isolated in hospitals throughout the world. The objectives of this study were to 
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investigate the antimicrobial resistance of coagulase-negative Staphylococci isolated in 8 consecutive 
years in the First Bethune Hospital. 
2.Materials and methods 
2.1.Bacterial isolates 
Consecutive nonduplicate nosocomial isolates of coagulase-negative Staphylococci were collected 
during the period from 2003 to 2010 in the First Bethune Hospital. Isolates were identified at the species 
level using standard biochemical tests and microbiological methods. 
2.2.Antimicrobial susceptibility testing 
The susceptibilities of coagulase-negative Staphylococci to 19 antimicrobial agents were determined 
by the disk diffusion method in accordance with Clinical and Laboratory Standards Institute (CLSI) 
guidelines. 
2.3.Detection of MRCNS 
Detection of MRCNS was according to CLSI. Staphylococci aureus ATCC 25923 and Staphylococci 
aureus ATCC 43300 strains served as quality controls.  
3.Results 
Distribution of specimen type: during the 8-year study period, 2484 consecutive clinical isolates of 
coagulase-negative Staphylococci were isolated. The strains were cultured from blood 925 (37.2%), 
secretions 652 (26.2%), urine 323 (13.0%), pus 250 (10.1%), bile 75 (3.0%), abdominal fluid 65 (2.6%), 
bone marrow 50 (2.0%), pleural fluid 45 (1.8%), tissue 30 (1.2%), others 69 (2.8%). 
The rates of MRCNS were 80.0% (164/205), 80.4% (181/225), 80.3% (196/244), 80.7% (180/223), 
81.5% (220/270), 79.4% (269/339), 80.2% (380/474), 81.3% (410/504) from 2003 to 2010, respectively. 
Resistance of MRCNS and MSCNS is shown in table 1  
4.Discussion 
Coagulase-negative staphylococci are important and frequently encountered pathogens in hospital 
environment, and they account for ~10% of all nosocomial infections [4-5]. Predominant 
Coagulase-negative staphylococci species associated with clinically relevant infections are 
Staphylococcus epidermidis followed by Staphylococcus haemolyticus and Staphylococcus hominis. The 
top three specimen types in the present study were blood, secretions and urine in the past 8 years in the 
First Bethune Hospital. It is emphasized that coagulase-negative Staphylococci are mainly responsible for 
bacteremia, wound infection and urinary infection in the First Bethune Hospital. 
The current study showed prevalence of MRCNS ranging from 79.4  to 81.5  in 
coagulase-negative Staphylococci in the First Bethune Hospita was higher in Canada and America[4-5]. It 
is associated with different geography, breakpoints, or antimicrobial susceptibility testing. Clinical 
laboratories need to have adequate equipment and expertise to provide detection method for MRCNS. 
Nosocomial MRCNS strains are frequently resistant to multiple antibiotics and may cause an overall 
increase in the incidence of staphylococcal infections in hospitals rather than simply replacing the more 
susceptible strains[6]. In addition to excellent activity of vancomycin, teicoplanin, rifampin and 
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gatifloxacin, the resistance rates of MRCNS for clindamycin, piperacillin/tazobactam, erythromycin, 
tetracycline, penicillin G, ampicilin, cefazolin, cefuroxime sodium, cefotaxime, cefepime, ciprofloxacin 
and levofloxacin were almost more than 50% during 8 years in the First Bethune Hospital. However, 
antimicrobial resistance of MSCNS to almost antibiotics except trimethoprim/sulfamethoxazole, 
clindamycin, erythromycin, penicillin G, and ampicilin were no more than 40.0 The resistance rates 
of MRCNS to the most antibiotics were much higher than those of MSCNS during 8 years in the First 
Bethune Hospital. Methicillin resistance is mediated via a chromosomally incorporated resistance gene, 
mecA, which confers altered binding of -lactams to penicillin binding protein 2a. The mecA gene is 
packaged in a cassette called the staphylococcal cassette cartridge (SCC), which aids in successful 
chromosomal incorporation [7]. 
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, 
cut costs and delay the emergence of resistant organisms. 
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TABLE 1   Antimicrobial resistance of coagulase-negative staphylococcus ( ) 
ANT 
2003 
(n=205) 
2004 
(n=225) 
2005 
(n=244) 
2006 
(n=223) 
2007 
(n=270) 
2008 
(n=339) 
2009 
(n=474) 
2010 
(n=504) 
MSC 
(n=41) 
MRC 
(n=164) 
MSC 
(n=44) 
MRC 
(n=181) 
MSC 
(n=48) 
MRC 
(n=196) 
MSC 
(n=43
) 
MRC 
(n=180) 
MSC 
(n=50
) 
MRC 
(n=220) 
MSC 
(n=70
) 
MRC 
(n=269) 
MSC 
(n=94
) 
MRC 
(n=380) 
MSC 
(n=94
) 
MRC 
(n=410) 
VAN 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TEC 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
FOX     0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0 
OXA 0.0 100.0 0.0 100.0             
SXT 31.7 73.2 34.1 71.8 39.6 73.8 37.2 78.3 38.0 78.6 40.0 78.1 40.4 78.9 42.6 80.5 
CLI 29.3 61.0 29.5 60.8 31.3 65.9 34.9 64.4 34.0 65.5 40.0 70.6 40.4 71.1 42.6 72.0 
RIF 4.9 20.1 6.8 20.4 6.3 19.8 14.3 24.6 14.0 22.7 10.0 22.3 13.8 21.1 14.9 23.2 
TZP 9.8 48.8 9.1 47.1 9.1 44.6 11.6 52.8 12.0 52.3 8.6 52.0 10.6 50.3 13.8 53.7 
ERY 53.7 94.5 54.5 93.9 52.6 95.7 65.1 89.4 62.0 95.5 64.3 95.9 69.1 96.1 74.5 96.3 
TCY 24.4 61.0 25.0 60.8 28.6 63.5 25.6 58.3 28.0 60.0 31.4 63.2 31.9 65.8 37.2 68.3 
PEN 53.7 100.0 56.8 100.0 61.9 100.0 55.8 100.0 62.0 100.0 71.4 100.0 78.7 100.0 85.1 100.0 
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AMP 53.7 100.0 56.8 100.0 61.9 100.0 55.8 100.0 62.0 100.0 71.4 100.0 78.7 100.0 85.1 100.0 
CZO 4.9 52.4 6.8 52.5 6.3 57.1 9.3 66.7 10.0 70.0 12.9 63.2 13.8 71.1 15.9 70.7 
CXM 7.3 54.9 9.1 55.2 6.3 61.2 11.6 72.2 12.0 70.0 15.7 70.6 17.0 78.9 19.1 73.2 
CTX 7.3 79.3 9.1 82.9 8.3 86.7 9.3 94.4 14.0 95.9 20.0 96.7 26.6 98.7 31.9 98.8 
FEP 7.3 78.7 9.1 82.3 8.3 87.2 11.6 95.0 14.0 95.9 20.0 96.3 26.6 97.6 31.9 97.8 
CIP 19.5 61.6 20.5 60.2 22.9 70.6 23.3 67.0 24.0 70.5 24.3 71.0 25.5 71.1 26.6 71.9 
LEV 12.2 42.3 13.6 40.3 16.7 43.1 18.6 48.9 18.0 50.0 20.0 53.2 20.2 53.9 22.3 54.9 
GAT 9.8 18.3 9.1 20.4 10.4 26.8 11.6 29.4 12.0 30.5 15.7 35.3 14.9 36.1 16.0 36.6 
Note: ANT: antibiotics, VAN: vancomycin, TEC: teicoplanin, FOX: cefoxitin, OXA: oxacillin, SXT: 
trimethoprim/sulfamethoxazole, CLI: clindamycin, RIF: rifampin, TZP: piperacillin/tazobactam, ERY: erythromycin, TCY: 
tetracycline, PEN: penicillin G, AMP: ampicilin, CZO: cefazolin, CXM: cefuroxime sodium, CTX: cefotaxime, FEP: cefepime, CIP: 
ciprofloxacin, LEV: levofloxacin, GAT: gatifloxacin, MSC: methicillin-sensitive coagulase-negative Staphylococcus, MRC: 
methicillin-resistant coagulase-negative Staphylococcus, : no data 
